Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Antonelli

Showing results (21-30 of 256) with videos related to

Pageof 26
Sort By:
Cytokine & Growth Factor Reviews|January 13, 2015
Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic useGuido Antonelli, Carolina Scagnolari, Federica Moschella, et al.
International Journal of Antimicrobial Agents|September 25, 2014
Is hepatitis C virus eradication around the corner only 25 years after its discovery?Giuseppe Ippolito, Maria Rosaria Capobianchi, Simone Lanini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 10, 2021
COVID-19 infodemics: the role of mainstream and social mediaDaniele Focosi, David Navarro, Fabrizio Maggi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 3, 2005
MxA and PKR expression in chronic hepatitis CGianluigi Giannelli, Graziana Guadagnino, Pietro Dentico, et al.
Expert Review of Anti-Infective Therapy|December 23, 2016
Consolidation of molecular testing in clinical virologyCarolina Scagnolari, Ombretta Turriziani, Katia Monteleone, et al.
Antibiotics (Basel, Switzerland)|January 20, 2021
Susceptibility Testing of Colistin for <i>Acinetobacter baumannii</i>: How Far Are We from the Truth?Federica Sacco, Paolo Visca, Federica Runci, et al.
Emerging Microbes & Infections|September 2, 2020
SARS-CoV-2 infection: diagnostic testing results occasionally require special attentionElisabetta Riva, Pier Paolo Sainaghi, Ombretta Turriziani, et al.
Hepatology (Baltimore, Md.)|August 27, 2003
Localization of hepatitis C virus in gastrointestinal mucosa: a possible reservoir for relapseLucia Miglioresi, Elisabetta Riva, Guido Antonelli, et al.
Virus Research|March 10, 2016
Investigation on torquetenovirus (TTV) microRNA transcriptome in vivoTiziano Vignolini, Lisa Macera, Guido Antonelli, et al.
International Journal of Antimicrobial Agents|January 5, 2023
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomicsDaniele Focosi, Scott McConnell, Shmuel Shoham, et al.
Pageof 26

Showing results (21-30 of 256) with videos related to

Sort By:
Pageof 26
Cytokine & Growth Factor Reviews|January 13, 2015
Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic useGuido Antonelli, Carolina Scagnolari, Federica Moschella, et al.
International Journal of Antimicrobial Agents|September 25, 2014
Is hepatitis C virus eradication around the corner only 25 years after its discovery?Giuseppe Ippolito, Maria Rosaria Capobianchi, Simone Lanini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 10, 2021
COVID-19 infodemics: the role of mainstream and social mediaDaniele Focosi, David Navarro, Fabrizio Maggi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 3, 2005
MxA and PKR expression in chronic hepatitis CGianluigi Giannelli, Graziana Guadagnino, Pietro Dentico, et al.
Expert Review of Anti-Infective Therapy|December 23, 2016
Consolidation of molecular testing in clinical virologyCarolina Scagnolari, Ombretta Turriziani, Katia Monteleone, et al.
Antibiotics (Basel, Switzerland)|January 20, 2021
Susceptibility Testing of Colistin for <i>Acinetobacter baumannii</i>: How Far Are We from the Truth?Federica Sacco, Paolo Visca, Federica Runci, et al.
Emerging Microbes & Infections|September 2, 2020
SARS-CoV-2 infection: diagnostic testing results occasionally require special attentionElisabetta Riva, Pier Paolo Sainaghi, Ombretta Turriziani, et al.
Hepatology (Baltimore, Md.)|August 27, 2003
Localization of hepatitis C virus in gastrointestinal mucosa: a possible reservoir for relapseLucia Miglioresi, Elisabetta Riva, Guido Antonelli, et al.
Virus Research|March 10, 2016
Investigation on torquetenovirus (TTV) microRNA transcriptome in vivoTiziano Vignolini, Lisa Macera, Guido Antonelli, et al.
International Journal of Antimicrobial Agents|January 5, 2023
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomicsDaniele Focosi, Scott McConnell, Shmuel Shoham, et al.
Pageof 26